Open Access
Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing
KONSTANTINOS AGIANNITOPOULOS, GEORGIA PEPE, GEORGIOS N. TSAOUSIS, KEVISA POTSKA, DIMITRA BOUZARELOU, ANASTASIA KATSELI, CHRISTINA NTOGKA, ANGELIKI MEINTANI, NIKOLAOS TSOULOS, STYLIANOS GIASSAS, VASSILEIOS VENIZELOS, CHRISTOS MARKOPOULOS, RODONIKI IOSIFIDOU, SOFIA KARAGEORGOPOULOU, CHRISTOS CHRISTODOULOU, IOANNIS NATSIOPOULOS, KONSTANTINOS PAPAZISIS, MARIA VASILAKI-ANTONATOU, ELEFTHERIOS KABLETSAS, AMANTA PSYRRI, DIMITRIOS ZIOGAS, EFTHALIA LALLA, ANNA KOUMARIANOU, KORNILIA ANASTASAKOU, CHRISTOS PAPADIMITRIOU, VAHIT OZMEN, SUALP TANSAN, KERIM KABAN, TAHSIN OZATLI, DAN TUDOR ENIU, ANGELICA CHIOREAN, ALEXANDRU BLIDARU, MARRIT RINSMA, EIRINI PAPADOPOULOU and GEORGE NASIOULAS
Cancer Genomics & Proteomics September 2023, 20 (5) 448-455; DOI: https://doi.org/10.21873/cgp.20396
